Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction.
Interleukin (IL)-5 binds to a cell surface receptor composed of two polypeptide chains, alpha and beta, both belonging to the hemopoietic cytokine receptor family. Mouse cells expressing common mouse beta chain (AIC2B) that were transfected with human IL-5 receptor (R)alpha cDNA proliferated in response to picomolar concentrations of human IL-5, indicating that a functional receptor was reconstituted. We show that in these cells, human (h)IL-5 as well as mouse (m)IL-3 induce tyrosine phosphorylation of beta chain and JAK 2 kinase. Phosphorylated beta receptor was co-precipitated with anti-JAK 2 antibodies, suggesting that both molecules were physically associated. IL-5 and IL-3 also induce cytosolic DNA binding activity as measured by an electrophoretic mobility shift assay using the interferon-gamma responsive region of human Fc gamma 1 gene DNA element. A deletion mutant of hIL-5R alpha lacking the cytoplasmic part could bind hIL-5 normally in association with the beta chain, but was unable to transmit a biological signal. The cytoplasmic domain was also indispensable for tyrosine phosphorylation and activation of DNA binding proteins. A membrane-proximal proline-rich element of the hIL-5R alpha cytoplasmic domain that is conserved among different members of the hemopoietic cytokine receptor family was essential for biological activity. Point mutations in this motif also knocked out IL-5-inducible JAK 2 phosphorylation.
Cornelis
S
S
Roche Research Gent, Ghent, Belgium.
Fache
I
I
Van der Heyden
J
J
Guisez
Y
Y
Tavernier
J
J
Devos
R
R
Fiers
W
W
Plaetinck
G
G
D000595:Amino Acid Sequence; D001483:Base Sequence; D002455:Cell Division; D003593:Cytoplasm / Q000648:ultrastructure; D004268:DNA-Binding Proteins / Q000378:metabolism; D004789:Enzyme Activation; D015848:Interleukin-5 / Q000502:physiology*; D053614:Janus Kinase 2; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides / Q000737:chemistry; D019000:Phosphotyrosine; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins; D017978:Receptors, Growth Factor / Q000502:physiology; D018123:Receptors, Interleukin / Q000502:physiology*; D053649:Receptors, Interleukin-5; D016415:Sequence Alignment; D017384:Sequence Deletion; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction; D013329:Structure-Activity Relationship; D014162:Transfection; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism
D004268:DNA-Binding Proteins; D015848:Interleukin-5; D009838:Oligodeoxyribonucleotides; D011518:Proto-Oncogene Proteins; D017978:Receptors, Growth Factor; D018123:Receptors, Interleukin; D053649:Receptors, Interleukin-5; D019000:Phosphotyrosine; D014443:Tyrosine; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; C507926:Jak2 protein, mouse; D053614:Janus Kinase 2